Palisade Asset Management, LLC Abbott Laboratories Transaction History

Palisade Asset Management, LLC

$1.02 Billion
Q3 2024

A detailed history of Palisade Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Palisade Asset Management, LLC holds 235,501 shares of ABT stock, worth $30.1 Million. This represents 2.64% of its overall portfolio holdings.

Number of Shares

235,501

Previous 239,468 1.66%

Holding current value

$30.1 Million

Previous $24.9 Million 7.9%

% of portfolio

2.64%

Previous 2.58%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $396,977 - $468,621	-3,967 Reduced 1.66%	235,501 $26.8 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $861,241 - $961,362	-8,550 Reduced 3.45%	239,468 $24.9 Million
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $4.26 Million - $4.7 Million	38,866 Added 18.58%	248,018 $28.2 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $139,253 - $170,457	1,544 Added 0.74%	209,152 $23 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $43,370 - $52,037	454 Added 0.22%	207,608 $20.1 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $263,741 - $293,862	2,617 Added 1.28%	207,154 $22.6 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $1.45 Million - $1.71 Million	-14,972 Reduced 6.82%	204,537 $20.7 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $1.33 Million - $1.56 Million	13,990 Added 6.81%	219,509 $24.1 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $335,273 - $388,183	3,465 Added 1.71%	205,519 $19.9 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $96,047 - $116,091	941 Added 0.47%	202,054 $22 Million
Q1 2022 Apr 21, 2022	BUY	$114.02 - $139.04 $261,105 - $318,401	2,290 Added 1.15%	201,113 $23.8 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $346,012 - $423,672	-2,995 Reduced 1.48%	198,823 $28 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $56,696 - $62,723	-486 Reduced 0.24%	201,818 $23.8 Million
Q2 2021 Jul 22, 2021	SELL	$105.79 - $124.53 $55,116 - $64,880	-521 Reduced 0.26%	202,304 $23.5 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $16,543 - $19,490	-152 Reduced 0.07%	202,825 $24.3 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $361,515 - $393,948	-3,443 Reduced 1.67%	202,977 $22.2 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $310,018 - $376,494	-3,383 Reduced 1.61%	206,420 $22.5 Million
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $1.51 Million - $1.93 Million	-19,672 Reduced 8.57%	209,803 $19.2 Million
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $137,198 - $200,622	-2,184 Reduced 0.94%	229,475 $18.1 Million
Q4 2019 Jan 16, 2020	SELL	$78.51 - $87.4 $14,602 - $16,256	-186 Reduced 0.08%	231,659 $20.1 Million
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $181,684 - $197,002	-2,220 Reduced 0.95%	231,845 $19.4 Million
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $81,406 - $94,945	-1,117 Reduced 0.47%	234,065 $19.7 Million
Q1 2019 Apr 15, 2019	SELL	$66.22 - $80.06 $4.39 Million - $5.31 Million	-66,366 Reduced 22.01%	235,182 $18.8 Million
Q4 2018 Jan 16, 2019	BUY	$65.56 - $74.27 $122,859 - $139,181	1,874 Added 0.63%	301,548 $21.8 Million
Q3 2018 Oct 19, 2018	SELL	$60.81 - $73.36 $121,620 - $146,720	-2,000 Reduced 0.66%	299,674 $22 Million
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $488,942 - $539,645	8,493 Added 2.9%	301,674 $18.4 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $308,528 - $348,828	5,483 Added 1.91%	293,181 $17.6 Million
Q4 2017 Feb 01, 2018	SELL	$53.68 - $57.47 $315,370 - $337,636	-5,875 Reduced 2.0%	287,698 $0
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $366,313 - $408,844	7,622 Added 2.67%	293,573 $15.7 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $13.7 Million - $15.3 Million	285,951	285,951 $15.3 Million

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Asset Management, LLC with notifications on news.

Account

Palisade Asset Management, LLC Abbott Laboratories Transaction History